Can’t see any conflict of interest. But MSD has to make decisions on what’s working and what’s not. Clearly the combo didn’t cut the mustard.
Efti, on the other hand, has been FDA fast tracked with Keytruda in Head and Neck. And there’s good chance it might happen in the lung cancer trial too.
The disparity in mkt cap between Imm and Imu shows how irrational the market can be.
Can’t see any conflict of interest. But MSD has to make...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.3¢ |
Change
-0.003(0.88%) |
Mkt cap ! $413.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $609.6K | 2.178M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 260786 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 226102 | 15 |
View Market Depth
| Last trade - 11.26am 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |